These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Caffeine and psychiatric symptoms: a review. Broderick P; Benjamin AB J Okla State Med Assoc; 2004 Dec; 97(12):538-42. PubMed ID: 15732884 [TBL] [Abstract][Full Text] [Related]
6. Caffeine and caffeinism. Mackay DC; Rollins JW J R Nav Med Serv; 1989; 75(2):65-7. PubMed ID: 2607498 [TBL] [Abstract][Full Text] [Related]
7. Use of the anxiety control questionnaire in psychiatric inpatients. Lang AJ; McNiel DE Depress Anxiety; 2006; 23(2):107-12. PubMed ID: 16400628 [TBL] [Abstract][Full Text] [Related]
8. Effect of Caffeine Consumption on the Risk for Neurological and Psychiatric Disorders: Sex Differences in Human. Jee HJ; Lee SG; Bormate KJ; Jung YS Nutrients; 2020 Oct; 12(10):. PubMed ID: 33050315 [TBL] [Abstract][Full Text] [Related]
9. Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students. Luebbe AM; Bell DJ J Sch Health; 2009 Aug; 79(8):380-7. PubMed ID: 19630872 [TBL] [Abstract][Full Text] [Related]
10. Structure of the computer-assisted Beck Anxiety Inventory with psychiatric inpatients. Steer RA; Rissmiller DJ; Ranieri WF; Beck AT J Pers Assess; 1993 Jun; 60(3):532-42. PubMed ID: 8336268 [TBL] [Abstract][Full Text] [Related]
11. Measurement and interrelations of psychiatric symptomatology in inpatients. Block P Psychol Rep; 1991 Jun; 68(3 Pt 1):1055-6. PubMed ID: 1891529 [TBL] [Abstract][Full Text] [Related]
12. [Psychological burden of patients diagnosed with obstructive sleep apnea]. Bratis D; Tselebis A; Zafeiropoulos G; Tsaraklis A; Dumitru S; Moussas G; Kosmas E; Koutsilieris M Psychiatriki; 2014; 25(2):95-103. PubMed ID: 25035178 [TBL] [Abstract][Full Text] [Related]
13. Caffeine and human behavior: arousal, anxiety, and performance effects. Sawyer DA; Julia HL; Turin AC J Behav Med; 1982 Dec; 5(4):415-39. PubMed ID: 7154064 [TBL] [Abstract][Full Text] [Related]
14. Withdrawal syndrome after the double-blind cessation of caffeine consumption. Silverman K; Evans SM; Strain EC; Griffiths RR N Engl J Med; 1992 Oct; 327(16):1109-14. PubMed ID: 1528206 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of Arab and Jewish patients admitted for psychiatric hospitalization in Jerusalem: the demographic, psychopathologic aspects, and the drug abuse comorbidity. Katz G; Grunhaus L; Deeb S; Shufman E; Bar-Hamburger R; Durst R Compr Psychiatry; 2012 Aug; 53(6):850-3. PubMed ID: 22197215 [TBL] [Abstract][Full Text] [Related]
16. Content validity of the Psychiatric Symptom Index, CES-depression Scale, and State-Trait Anxiety Inventory from the perspective of DSM-IV. Okun A; Stein RE; Bauman LJ; Silver EJ Psychol Rep; 1996 Dec; 79(3 Pt 1):1059-69. PubMed ID: 8969117 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. Lueboonthavatchai P J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438 [TBL] [Abstract][Full Text] [Related]
18. Anxiety and caffeine consumption in people with anxiety disorders. Lee MA; Cameron OG; Greden JF Psychiatry Res; 1985 Jul; 15(3):211-7. PubMed ID: 3862156 [TBL] [Abstract][Full Text] [Related]
19. Association of periodontal disease to anxiety and depression symptoms, and psychosocial stress factors. Solis AC; Lotufo RF; Pannuti CM; Brunheiro EC; Marques AH; Lotufo-Neto F J Clin Periodontol; 2004 Aug; 31(8):633-8. PubMed ID: 15257740 [TBL] [Abstract][Full Text] [Related]
20. Comparison of changes in physical self-concept, global self-esteem, depression and anxiety following two different psychomotor therapy programs in nonpsychotic psychiatric inpatients. Knapen J; Van de Vliet P; Van Coppenolle H; David A; Peuskens J; Pieters G; Knapen K Psychother Psychosom; 2005; 74(6):353-61. PubMed ID: 16244511 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]